Demonstration Formulary
4 Central nervous system
PALLIATIVE CARE PHYSICIANS - Guidelines for the use of drugs in symptom control
04-03-02 Reverible MAOIs
Links
Administration of depot antipsychotic injections during COVID-19 in stable adult patients
NICE CG26: Post-traumatic stress disorder (PTSD)- NICE CG28: Depression in children and young people
- NICE CG53: Chronic fatigue syndrome / Myalgic encephalomyelitis
- NICE CG90: Depression in adults (update)
- NICE CG91: Depression with a chronic physical health problem
UKMI Q&A: Can breastfeeding mothers take SSRI's?- UKMI Q&A: Depression in breastfeeding mothers- Are reboxetine, venlafaxine, duloxetine, mirtazapine and MAOIs safe?
- UKMI Q&A: Epileptics - What is the most appropriate antidepressant to use?
- UKMI Q&A: Interaction risk between opioid analgesics and monoamine oxidase inhibitors (MAOIs)?
- UKMI Q&A: Management of depression in breast feeding mothers - Are St.John’s Wort and other complementary therapies safe?
- UKMI Q&A: Switching between monoamine oxidase inhibitors and SSRIs/TCAs
- UKMI Q&A: What is the first choice antidepressant for patients with renal impairment?